METROVACESA S.A. |
Market Closed -
Other stock markets
|
After market 12:02:20 pm | |||
| 8.45 EUR | +1.08% |
|
8.455 | +0.06% |
| Feb. 28 | Transcript : Metrovacesa S.A., 2023 Earnings Call, Feb 28, 2024 | |
| Feb. 27 | Metrovacesa S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- This company will be of major interest to investors in search of a high dividend stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an expected P/E ratio at 37.76 and 30.47 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Development & Operations
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.58% | 1.35B | B+ | ||
| -8.37% | 22.5B | A- | ||
| +8.24% | 10.79B | - | B- | |
| -34.32% | 10.32B | B+ | ||
| -27.74% | 7.2B | - | B+ | |
| -5.56% | 7.01B | C- | ||
| -0.34% | 6.53B | C+ | ||
| -2.27% | 6.09B | A- | ||
| +12.96% | 3.57B | - | ||
| -5.92% | 3.54B | C |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- MVC Stock
- Ratings Metrovacesa S.A.
